![Brad Geddes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brad Geddes
Plus aucun poste en cours
Profil
Brad Geddes is the founder of Resilience Therapeutics, Inc. He previously worked as a Senior Director of Drug Discovery at Elixir Pharmaceuticals, Inc. and as a Principal at MDS Proteomics, Inc. He also worked as a Principal at Millennium Pharmaceuticals, Inc. for a brief period.
Dr. Geddes received his undergraduate and graduate degrees from the University of Guelph and his doctorate from the University of Bristol.
Anciens postes connus de Brad Geddes
| Sociétés | Poste | Fin |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/01/2003 |
Resilience Therapeutics, Inc.
 Resilience Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates in the healthcare industry focusing on pharmaceutical business | Fondateur | - |
MDS Proteomics, Inc.
 MDS Proteomics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and analyzes proteins to determine their role in disease | Corporate Officer/Principal | - |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases | Corporate Officer/Principal | - |
Formation de Brad Geddes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
MDS Proteomics, Inc.
MDS Proteomics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and analyzes proteins to determine their role in disease | Commercial Services |
Resilience Therapeutics, Inc.
Resilience Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates in the healthcare industry focusing on pharmaceutical business | Health Technology |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases | Miscellaneous |
University of Guelph
 University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
